Below are the most recent publications written about "Prodrugs" by people in Profiles.
-
Nabawy A, Gupta A, Jiang M, Hirschbiegel CM, Fedeli S, Chattopadhyay AN, Park J, Zhang X, Liu L, Rotello VM. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics. Nanoscale. 2023 Aug 25; 15(33):13595-13602.
-
Hirschbiegel CM, Zhang X, Huang R, Cicek YA, Fedeli S, Rotello VM. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts. Adv Drug Deliv Rev. 2023 04; 195:114730.
-
Zhang X, Lin S, Huang R, Gupta A, Fedeli S, Cao-Mil?n R, Luther DC, Liu Y, Jiang M, Li G, Rondon B, Wei H, Rotello VM. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics. J Am Chem Soc. 2022 07 20; 144(28):12893-12900.
-
Zhang X, Landis RF, Keshri P, Cao-Mil?n R, Luther DC, Gopalakrishnan S, Liu Y, Huang R, Li G, Malassin? M, Uddin I, Rondon B, Rotello VM. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts. Adv Healthc Mater. 2021 03; 10(5):e2001627.
-
Kristeleit R, Evans J, Molife LR, Tunariu N, Shaw H, Slater S, Haris NRM, Brown NF, Forster MD, Diamantis N, Rulach R, Greystoke A, Asghar U, Rata M, Anderson S, Bachmann F, Hannah A, Kaindl T, Lane HA, Larger PJ, Schmitt-Hoffmann A, Engelhardt M, Tzankov A, Plummer R, Lopez J. Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours. Br J Cancer. 2020 10; 123(9):1360-1369.
-
Huang L, Zhao Y, Zhang H, Huang K, Yang J, Han G. Expanding Anti-Stokes Shifting in Triplet-Triplet Annihilation Upconversion for In Vivo Anticancer Prodrug Activation. Angew Chem Int Ed Engl. 2017 11 13; 56(46):14400-14404.
-
Henssen AG, Odersky A, Szymansky A, Seiler M, Althoff K, Beckers A, Speleman F, Sch?fers S, De Preter K, Astrahanseff K, Struck J, Schramm A, Eggert A, Bergmann A, Schulte JH. Targeting tachykinin receptors in neuroblastoma. Oncotarget. 2017 Jan 03; 8(1):430-443.
-
Wong KE, Mora MC, Skinner M, McRae Page S, Crisi GM, Arenas RB, Schneider SS, Emrick T. Evaluation of PolyMPC-Dox Prodrugs in a Human Ovarian Tumor Model. Mol Pharm. 2016 05 02; 13(5):1679-87.
-
Van Dessel N, Swofford CA, Forbes NS. Potent and tumor specific: arming bacteria with therapeutic proteins. Ther Deliv. 2015 Mar; 6(3):385-99.
-
Khvorova A, Osborn MF, Hassler MR. Taking charge of siRNA delivery. Nat Biotechnol. 2014 Dec; 32(12):1197-8.